Revision history of "Scientific outcomes and basic safety regarding apatinib monotherapy within the treatment of individuals using advanced epithelial ovarian carcinoma which advanced right after standard routines and the investigation VEGFR2 polymorphism"

Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 02:07, 28 March 2024Secondcolony41 (talk | contribs). . (3,675 bytes) (+3,675). . (Created page with "39 mm (+1.96σ). The typical price of pulvinar thickness had been 2.67 mm ± 0.78 mm, with the top limit of four years old.20 mm (+1.96σ). Many of us identified s...")